Institutional investors purchased a net $731.7 thousand shares of BIOC during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 5.85% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 411.4 Thousand shares of Biocept Inc
GOLDMAN CAPITAL MANAGEMENT, INC. Bought 225.0 Thousand shares of Biocept Inc
THE VANGUARD GROUP, INC. Bought 81.1 Thousand shares of Biocept Inc